Inmune Bio Files 8-K for Disclosure and Exhibits
Ticker: INMB · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, exhibits, sec-filing
Related Tickers: INMB
TL;DR
INMB filed an 8-K. Standard disclosure stuff, check exhibits for details.
AI Summary
On April 16, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Inmune Bio is providing updates and required documentation to the SEC, which is standard for public companies but may contain important operational or financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and exhibits, not indicating any immediate negative events.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- April 16, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 475205835 (identifier) — IRS Employer Identification No.
- 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432 (address) — Principal Executive Offices
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific information disclosed under Regulation FD, only that it is a category of the filing.
What financial statements or exhibits are included in this filing?
The excerpt states that 'Financial Statements and Exhibits' are part of the filing, but does not list or describe them.
Has Inmune Bio, Inc. changed its name or former address recently?
The filing states 'Not Applicable' for 'Former Name or Former Address, If Changed Since Last Report', indicating no recent changes.
What is the Standard Industrial Classification for Inmune Bio, Inc.?
The Standard Industrial Classification for Inmune Bio, Inc. is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What is the exact date of the earliest event reported in this 8-K?
The exact date of the earliest event reported is April 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Inmune Bio, Inc. (INMB).